BCG δzmp1 vaccine induces enhanced antigen specific immune responses in cattle

Vaccine

Volumn 32, Issue 7, 2014, Pages 779-784

  Khatri, Bhagwati ^a   Whelan, Adam ^a   Clifford, Derek ^a   Petrera, Agnese ^b   Sander, Peter ^b,c   Vordermeier, H Martin ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Nationales Zentrum fur Mykobakterien   (Switzerland)

Author keywords

BCG; Bovine tuberculosis; Cattle; Tuberculosis; Zinc metalloprotease 1 deletion

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ARTICLE; BOVINE TUBERCULOSIS; CATTLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; ESCHERICHIA COLI; EX VIVO STUDY; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTE CULTURE; MEMORY T LYMPHOCYTE; MYCOBACTERIUM BOVIS; NONHUMAN; PHAGOSOME; PHENOTYPE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; WILD TYPE;

BCG; BOVINE TUBERCULOSIS; CATTLE; TUBERCULOSIS; ZINC METALLOPROTEASE 1 DELETION;

ANIMALS; BCG VACCINE; CATTLE; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; MALE; MYCOBACTERIUM BOVIS; PERFORIN; T-LYMPHOCYTES; TUBERCULOSIS, BOVINE; VACCINATION; VACCINES, SYNTHETIC;

EID: 84892869626     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.12.055     Document Type: Article

References (37)

1. Pollock J.M., Neill S.D. Mycobacterium bovis infection and tuberculosis in cattle. Veterinary Journal 2002, 163:115-127.
2. Hewinson R.G., Vordermeier H.M., Buddle B.M. Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics. Tuberculosis 2003, 83:119-130.
3. Fine P.E. The BCG story: lessons from the past and implications for the future. Reviews of Infectious Diseases 1989, 11(Suppl 2):S353-S359.
4. Waters W.R., Palmer M.V., Buddle B.M., Vordermeier H.M. Bovine tuberculosis vaccine research: historical perspectives and recent advances. Vaccine 2012, 30:2611-2622.
5. Vordermeier M., Hewinson R.G. Development of cattle TB vaccines in the UK. Veterinary Immunology and Immunopathology 2006, 112:38-48.
6. Rohde K., Yates R.M., Purdy G.E., Russell D.G. Mycobacterium tuberculosis and the environment within the phagosome. Immunological Reviews 2007, 219:37-54.
7. Kovacsovics-Bankowski M., Rock K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science (New York, NY) 1995, 267:243-246.
8. Raghavan M., Del Cid N., Rizvi S.M., Peters L.R. MHC class I assembly: out and about. Trends in Immunology 2008, 29:436-443.
9. Pancholi P., Mirza A., Bhardwaj N., Steinman R.M. Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages. Science (New York, NY) 1993, 260:984-986.
10. Vyas J.M., Van der Veen A.G., Ploegh H.L. The known unknowns of antigen processing and presentation. Nature Reviews Immunology 2008, 8:607-618.
11. Master S.S., Rampini S.K., Davis A.S., Keller C., Ehlers S., Springer B., et al. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host & Microbe 2008, 3:224-232.
12. Ferraris D.M., Sbardella D., Petrera A., Marini S., Amstutz B., Coletta M., et al. Crystal structure of Mycobacterium tuberculosis zinc-dependent metalloprotease-1 (Zmp1), a metalloprotease involved in pathogenicity. Journal of Biological Chemistry 2011, 286:32475-32482.
13. Petrera A., Amstutz B., Gioia M., Hahnlein J., Baici A., Selchow P., et al. Functional characterization of the Mycobacterium tuberculosis zinc metallopeptidase Zmp1 and identification of potential substrates. Biological Chemistry 2012, 393:631-640.
14. Sander P., Meier A., Bottger E.C. rpsL+: a dominant selectable marker for gene replacement in mycobacteria. Molecular Microbiology 1995, 16:991-1000.
15. Sander P., Papavinasasundaram K.G., Dick T., Stavropoulos E., Ellrott K., Springer B., et al. Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild-type survival in a mouse infection model. Infection and Immunity 2001, 69:3562-3568.
16. Vordermeier M., Whelan A.O. ELISPOT assays to enumerate bovine IFN-gamma-secreting cells for the development of novel vaccines against bovine tuberculosis. Methods in Molecular Biology 2012, 792:219-227.
17. Vordermeier H.M., Chambers M.A., Cockle P.J., Whelan A.O., Simmons J., Hewinson R.G. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infection and Immunity 2002, 70:3026-3032.
18. Waters W.R., Palmer M.V., Nonnecke B.J., Thacker T.C., Scherer C.F., Estes D.M., et al. Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves. Vaccine 2009, 27:1201-1209.
19. Hope J.C., Thom M.L., McAulay M., Mead E., Vordermeier H.M., Clifford D., et al. Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish. Clinical and Vaccine Immunology: CVI 2011, 18:373-379.
20. Whelan A.O., Wright D.C., Chambers M.A., Singh M., Hewinson R.G., Vordermeier H.M. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations. Vaccine 2008, 26:166-173.
21. Pipkin M.E., Lieberman J. Delivering the kiss of death: progress on understanding how perforin works. Current Opinion in Immunology 2007, 19:301-308.
22. Peters P.J., Borst J., Oorschot V., Fukuda M., Krahenbuhl O., Tschopp J., et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. Journal of Experimental Medicine 1991, 173:1099-1109.
23. Russell J.H., Ley T.J. Lymphocyte-mediated cytotoxicity. Annual Review of Immunology 2002, 20:323-370.
24. Pieters J. Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host & Microbe 2008, 3:399-407.
25. Ramachandra L., Smialek J.L., Shank S.S., Convery M., Boom W.H., Harding C.V. Phagosomal processing of Mycobacterium tuberculosis antigen 85B is modulated independently of mycobacterial viability and phagosome maturation. Infection and Immunity 2005, 73:1097-1105.
26. Torres M., Ramachandra L., Rojas R.E., Bobadilla K., Thomas J., Canaday D.H., et al. Role of phagosomes and major histocompatibility complex class II (MHC-II) compartment in MHC-II antigen processing of Mycobacterium tuberculosis in human macrophages. Infection and Immunity 2006, 74:1621-1630.
27. Grode L., Seiler P., Baumann S., Hess J., Brinkmann V., Nasser Eddine A., et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. Journal of Clinical Investigation 2005, 115:2472-2479.
28. Desel C., Dorhoi A., Bandermann S., Grode L., Eisele B., Kaufmann S.H. Recombinant BCG DeltaureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses. Journal of Infectious Diseases 2011, 204:1573-1584.
29. Farinacci M., Weber S., Kaufmann S.H. The recombinant tuberculosis vaccine rBCG DeltaureC::hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells. Vaccine 2012, 30:7608-7614.
30. Johansen P., Fettelschoss A., Amstutz B., Selchow P., Waeckerle-Men Y., Keller P., et al. Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens. Clinical and Vaccine Immunology 2011, 18:907-913.
31. Ly L.H., McMurray D.N. Tuberculosis: vaccines in the pipeline. Expert Review of Vaccines 2008, 7:635-650.
32. Bhuju S., Aranday-Cortes E., Villarreal-Ramos B., Xing Z., Singh M., Vordermeier H.M. Global gene transcriptome analysis in vaccinated cattle revealed a dominant role of IL-22 for protection against bovine tuberculosis. PLoS Pathogens 2012, 8:e1003077.
33. Vordermeier H.M., Dean G.S., Rosenkrands I., Agger E.M., Andersen P., Kaveh D.A., et al. Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model. Clinical and Vaccine Immunology: CVI 2009, 16:1443-1448.
34. Waters W.R., Buddle B.M., Vordermeier H.M., Gormley E., Palmer M.V., Thacker T.C., et al. Development and evaluation of an enzyme-linked immunosorbent assay for use in the detection of bovine tuberculosis in cattle. Clinical and Vaccine Immunology: CVI 2011, 18:1882-1888.
35. Thom M.L., McAulay M., Vordermeier H.M., Clifford D., Hewinson R.G., Villarreal-Ramos B., et al. Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guerin Danish: significant protection against infection at 12, but not 24, months. Clinical and Vaccine Immunology: CVI 2012, 19:1254-1260.
36. Godkin A.J., Thomas H.C., Openshaw P.J. Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus. Journal of Immunology 2002, 169:2210-2214.
37. Wang J.J., Hu C., Lee F., Shaio M.F., Chen L.K. Internalization of CD4 molecules in human T-cells demonstrated by immuno-electron microscopy. Histochemistry 1992, 97:51-59.